For more than 30 years, Alcimed has been supporting the leaders of the aeronautics, space and defense sector in their innovation and new market development projects. The team supports everyday major industry players (integrators, equipment manufacturers, operators, etc.) and institutions on a wide variety of challenges: industry 4.0, cybersecurity, the client experience, new energy sources, new space, drones, digital sovereignty, and more. Projects cover diverse subjects such as state of the art, market studies, identifying new technologies, developing road maps, implementing circular economy models, improving the client experience, defining supply chain strategies, developing new sectors, launching innovations, studying new usages, driving prospective analyses, re-making business models, identifying partners, and many more.

Alcimed's agrifood team supports everyday players all along the agrifood value chain: from agribusiness up until packaging, working on a large variety of projects linked to agrifood, including agroecology, precision agriculture, bioproduction, plant proteins, clean label, sustainable packaging, and more. Projects cover diverse subjects such as state of the art, market studies, receptivity analyses, identifying new technologies, implementing circular economy models, adding value to by-products, defining clean label strategies, developing new sectors, launching innovations, identifying partners, and many more.

Alcimed's healthcare team supports everyday biotech players in a large variety of challenges in their sector: bioproduction, DTx, rare diseases, time-to-market, partnerships, artificial intelligence, market access, and more. Projects cover diverse subjects such as new therapeutic technologies and approaches, commercial R&D strategies, comprehension of disease treatment and care pathways, market opportunity and licensing evaluations, developing business plans and roadmaps, market access, regulatory evolution, partner search, and many more.

For more than 30 years, Alcimed has been supporting the leaders of the chemical and materials sector in their innovation and new market development projects. The team supports everyday major industry players in chemistry, materials manufacturing, and formulation on a wide variety of challenges: circular economy, responding to CSR requirements, biosourced materials, product and process innovation, sovereignty, digitization, and more. Projects cover diverse subjects such as state of the art, market studies, identifying new technologies, defining CSR or decarbonation strategy (including building materiality matrices), developing road maps, defining supply chain strategies, developing new sectors, launching innovations, re-making business models, identifying partners, and many more.

Alcimed's cosmetics team supports everyday the players in the cosmetics and luxury sector — both the brands and their partners — on a wide variety of challenges: conquering new markets, ultra-personalization, holistic approaches to well-being, improving ecological imprints, and more. Projects cover diverse subjects such as state of the art, market studies, identifying new technologies, defining supply chain strategies, launching innovations, defining new consumer experiences, re-making innovation processes, identifying partners, and many more.

For more than 30 years, Alcimed has been supporting the leaders of the energy and environment sector in their innovation and new market development projects. The team supports everyday players all along the value chain of energy, but also the major players in water, waste, and air quality on a wide variety of challenges: mitigating and adapting to climate change, resource scarcity, renewable energies, CCUS, sovereignty, and more. Projects cover diverse subjects such as state of the art, market studies, identifying new technologies, developing road maps, defining supply chain strategies, developing new sectors, launching innovations, re-making business models, identifying partners, and many more.

For more than 30 years, Alcimed has been supporting the leaders of the healthcare sector in their innovation and new market development projects. The team supports everyday pharmaceutical companies, biotechs, but also medical device, diagnostic, vaccine and animal health players in a wide variety of challenges: evolution of care pathways, innovative therapies, AI in healthcare, digitization of clinical trials, market access, and more. Projects cover diverse subjects such as new therapeutic technologies and approaches, preparing for new medication launches, understanding the management of diseases and care pathways, evaluating market opportunities and licensing, market access, regulatory evolution, and many more.

Alcimed's mobility team supports everyday the leaders of the public transportation, rail, and automotive industries in a variety of mobility-related challenges: new mobilities, connected mobility, autonomous modules, V2G, emission reduction, alternative fuels, and more. Projects cover diverse subjects such as state of the art, market studies, identifying new technologies, developing road maps, developing new sectors, launching innovations, re-making business models, identifying partners, and many more.

For more than 30 years, Alcimed has been supporting investment funds in their equity investments and the development of their portfolio companies. The team supports everyday investment funds in their due diligence strategies and in a wide variety of challenges of their portfolio companies: strategic positioning, build-up strategy, commercial strategy, threats of new entrants, impact of digitization and artificial intelligence, and more. Projects cover diverse subjects such as strategic due diligence for buyers and sellers, strategic audits, market studies, defining development strategies, building road maps, and many more.

Alcimed supports everyday public sector players in their innovation and new business projects, working across sector exploration, implementing new innovation approaches, economic development of territories and their ecosystems, implementing large-scale public-private partnerships and projects, structuring roadmaps, optimization of care pathways, and many more. The team works with public institutions including regional health agencies, national bodies, and other government organisations navigating complex innovation and policy challenges.

Provides end-to-end commercial development support from pitch construction and prospect identification to negotiation and first contract generation for new products, services, and market entries. Enables organizations to systematically build pipelines, identify priority prospects, and convert opportunities into revenue. Demonstrated through supporting market entry into North American dressing markets by identifying 300 potential companies, qualifying 50 priority prospects, and securing 10 key client calls for silicone industrial players; supporting pharmaceutical New Business Development teams in identifying and analyzing potential SME partners; and building commercial roadmaps to expand insulin access across African markets. Capabilities span prospect identification, qualification, pitch development, and deal closure support.

Advises clients on digital strategy, digital services development, and the integration of AI, data science, and digital tools into operations and business models. Enables organizations to leverage digital and analytics capabilities to create new service offerings and operational efficiencies. Demonstrated through defining digital services offerings for aeronautical operators, investigating AI risk prediction models for financial services, and developing integrated digital strategies across multi-site industrial operations. Supports both revenue-focused digital service development and operational transformation through technology enablement.

Helps clients build and improve innovation strategies, lead open innovation approaches, run creativity seminars, define eco-design strategies, and model innovation impact on CSR. Capabilities enable organizations to systematically develop new products, services, and market access models through structured innovation frameworks. Demonstrated through creation of innovation laboratories for pharmaceutical leaders, launching open innovation challenges in energy and robotics, and building Test & Learn methodologies for innovation maturation. Eco-design strategy definition supports product stewardship and circular economy integration.

Builds market access strategies to help clients register and launch new products or services, particularly in the pharmaceutical field, navigating payer, regulatory, and reimbursement landscapes. Enables successful product commercialization by systematically addressing market entry barriers and stakeholder requirements. Demonstrated through defining market access strategies for CAR-T therapy launch across USA, Canada, and Europe; assessing orphan drug market access factors across 9 emerging countries; and preparing European launch strategies for innovative digital surgery platforms. Capabilities span regulatory navigation, reimbursement strategy, and multi-market launch orchestration.

Provides in-depth or flash market studies to understand market offer, demand, trends, and potential, enabling clients to best position their company, products, or services. Delivers actionable market intelligence to inform strategic positioning and economic valorization strategies. Demonstrated through conducting 14 consecutive market studies for a public research institute's economic valorization strategy, assessing Single-Pilot Aircraft market receptivity for aeronautics, and providing exploratory market views on EV charging infrastructure positioning. Capabilities support both strategic positioning and new market entry planning.

Supports clients in strategic audits, roadmaps, strategic positioning, diversification strategies, due diligence, asset valuation, and business model (re)definition. Services enable organizations to validate key strategic decisions and secure stakeholder support through comprehensive roadmap development and positioning frameworks. Demonstrated across life sciences, automotive, and pharmaceutical sectors, capabilities include co-constructing multi-year strategic roadmaps, defining competitive positioning for emerging categories (autonomous vehicles), and developing commercial strategies to support market entry. Valuation and business planning capabilities underpin transaction and due diligence support.

Helps clients define CSR strategies, implement circular economy models, build materiality matrices, develop eco-design approaches, and align with UN Sustainable Development Goals. Enables organizations to systematically integrate sustainability into strategy and operations while communicating impact to stakeholders. Demonstrated through validating CSR strategies and SDG selections with ecosystem KOLs for phytosanitary/seed leaders, building materiality matrices and stakeholder benchmarking frameworks for CSR communication, and reducing environmental impact through bulk product transformation for cosmetics players. Supports both strategy definition and implementation, including stakeholder engagement and materiality assessment.

Investigates emerging technologies, conducts technology scouting, and evaluates technology readiness to help clients develop new offerings and competitive advantages. Capabilities encompass systematic horizon scanning and maturity assessment to de-risk technology adoption and innovation. Demonstrated through Factory 4.0 design and benchmarking for aircraft production, smart sensor identification and evaluation for connected medical devices, and NLP-based dashboard development for oncology diagnostics. Enables clients to assess feasibility and competitive positioning of technology-enabled solutions.